Green tea consumption may prevent, treat prostate cancer
the ONA take:
According to a new study published in the journal The Prostate, brewed green tea may have a role a in the prevention and treatment of prostate cancer and other prostate conditions like prostatitis.
For the exploratory, open label, phase 2 study, researchers sought to investigate the effect of green tea and black tea consumption on prostate cancer biomarkers.
They enrolled 113 men with prostate cancer and randomly assigned them to consume six cups daily of brewed green tea, black tea, or water before undergoing a radical prostatectomy. Of the 113 patients enrolled, 93 completed the study. Results showed no significant difference in biomarkers that measure proliferation, apoptosis, or oxidation in radical prostatectomy tissue among the three groups.
A biomarker that measures inflammation, called NFκB was significantly lower in the tissue of men that consumed green tea compared with those who consumed water (P = 0.013), but there was no difference between black tea and water (P = 0.931). In addition, nearly all of the men who consumed green tea had tea polyphenols detected in their prostate tissue, but no men who consumed black tea were found to have the chemicals.
Furthermore, those who consumed green tea had evidence of a systemic antioxidant effect (P = 0.03) and a small but statistically significant PSA level reduction (P = 0.04). The findings suggest that further studies to examine the effect of green tea on prostate cancer prevention and treatment are warranted.
Green tea may have a role a in the prevention and treatment of prostate cancer and other prostate conditions like prostatitis.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- Ruxolitinib Effective as Long-term Treatment Option for Polycythemia Vera
- Definitive IMRT Associated With Shorter Feeding Tube Placement Duration in HNC
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|